Alex Tarrabain - 31 Dec 2017 Form 5/A - Amendment Insider Report for CEN BIOTECH INC

Role: Chief Financial Officer, Director
Signature: /s/ Alex Tarrabain
Issuer symbol: N/A
Transactions as of: 31 Dec 2017
Net transactions value: $0
Form type: 5/A - Amendment
Filing time: 28 May 2021, 08:31:10 UTC
Date Of Original Report: 26 Apr 2021
Next filing: 03 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CENBF	Common Stock	Award	$0	+20,000	+25%	$0.000000	99,942	30 Nov 2017	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	20,000 shares of common stock of the issuer were granted by the issuer on November 30, 2017, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.
F2	99,942 shares were beneficially owned by the Reporting Person of which 30,000 shares were issuable upon conversion of a convertible note held by the Reporting Person at 12/31/2017.

Remarks:

On July 12, 2017, Alex Tarrabain (the "Reporting Person") was appointed as a director of the issuer. On May 21, 2019, the Reporting Person was appointed as the Chief Financial Officer of the issuer.